Global pharmaceutical manufacturer and biotech company AstraZeneca plans to construct a multibillion dollar manufacturing center focused on chronic diseases in Virginia within the next five years, it ...
From Left to right: Enitan Odeyemi, Director, Business Development, Codix Pharma Ltd; Mary Ogangwu - Chief Operating Officer, Codix Pharma Ltd; Kingsley Aguoru - Chief Operating Officer, Colexa ...
As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the ...
Richmond pharmaceutical manufacturing company Phlow announced Tuesday that it had raised $37 million in a Series C funding round led by Align Private Capital. The funding round, which was also ...
Fujifilm Biotechnologies will open a new biologics manufacturing plant in the U.S. this fall, with Regeneron and Johnson & Johnson as the initial customers. The Holly Springs, North Carolina, site is ...
In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...
Bristol Myers Squibb is yet another example of a Big Pharma company pledging a multibillion dollar investment in the U.S. as the Trump administration tries to woo drugmakers to boost their domestic ...
Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical manufacturing landscape is undergoing a ...
Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities Agno ...
Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcomin ...
Get the latest SMS Pharmaceuticals share price today on NSE & BSE. Explore SMS Pharmaceuticals stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...